Tag: Triad Life Sciences
ConvaTec enters new market
January 31, 2022HME News Staff
BRIDGEWATER, N.J. – ConvaTec will enter the wound biologics segment with its planned acquisition of Memphis, Tenn.-based Triad Life Sciences for an initial consideration of $125 million.
The company says the wound biologics segment is estimated to be worth $1.8 billion per year globally.
“Today’s announcement marks another successful step in our strategic intent of pivoting to sustainable and profitable growth,” said Karim Bitar, CEO of ConvaTec. “This...